Alfredo Bardají Ruiz-rekin lankidetzan egindako argitalpenak (12)

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

2020

  1. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

2018

  1. Characteristics and Outcomes of Patients Hospitalized With Suspected Acute Coronary Syndrome in Whom the Diagnosis is not Confirmed

    American Journal of Cardiology, Vol. 122, Núm. 10, pp. 1604-1609

2015

  1. Prognosis and management of acute coronary syndrome in Spain in 2012: The DIOCLES study

    Revista Espanola de Cardiologia, Vol. 68, Núm. 2, pp. 98-106

2013

  1. Fracción aminoterminal del propéptido natriurético cerebral y troponina ultrasensible en el dolor torácico agudo de origen incierto. Un subestudio del estudio PITAGORAS

    Revista Espanola de Cardiologia, Vol. 66, Núm. 7, pp. 532-538

2012

  1. Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation. A report of the task force of the clinical practice guidelines committee of the Spanish society of cardiology

    Revista Espanola de Cardiologia, Vol. 65, Núm. 2, pp. 125-130

  2. Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage

    American Heart Journal, Vol. 164, Núm. 2

2010

  1. Ischemic heart disease: 2009 Update

    Revista Espanola de Cardiologia, Vol. 63, Núm. SUPPL. 1, pp. 49-60

2009

  1. Update on Ischemic Heart Disease

    Revista Espanola de Cardiologia Suplementos, Vol. 9, Núm. 1, pp. 80-91

  2. Update on ischemic heart disease

    Revista Espanola de Cardiologia, Vol. 62, Núm. SUPPL. 1, pp. 80-91

2008

  1. Actualización en cardiopatía isquémica

    Revista Espanola de Cardiologia, Vol. 61, Núm. SUPPL. 1, pp. 37-47

1999

  1. Echocardiographic evaluation in patients with autosomal dominant polycystic kidney disease and end-stage renal disease

    American Journal of Kidney Diseases, Vol. 34, Núm. 2, pp. 264-272